Collectively, these findings suggest that the brain aging clock can robustly predict and stratify future dementia risk across different disease stages and APOE haplotypes, independently of established biomarkers, while also uncovering distinct pathogenic pathways that link brain aging-related changes to AD. This evidence concerns the gene APOE and Alzheimer disease.